scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF01406044 |
P953 | full work available at URL | http://link.springer.com/article/10.1007/BF01406044/fulltext.html |
http://link.springer.com/content/pdf/10.1007/BF01406044 | ||
http://link.springer.com/content/pdf/10.1007/BF01406044.pdf | ||
P698 | PubMed publication ID | 6234754 |
P2093 | author name string | B. M. Nikiforov | |
V. A. Shustin | |||
Y. N. Zubkov | |||
P2860 | cites work | TRANSLUMINAL TREATMENT OF ARTERIOSCLEROTIC OBSTRUCTION. DESCRIPTION OF A NEW TECHNIC AND A PRELIMINARY REPORT OF ITS APPLICATION | Q28201161 |
Perspectives in aneurysm surgery | Q36647540 | ||
Pathological study of late arterial spasm (author's transl) | Q39582813 | ||
A comparison of intimal proliferation in experimental subarachnoid hemorrhage and atherosclerosis | Q41732543 | ||
Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study | Q48170883 | ||
Calcium ions and calcium antagonists in ischaemia | Q49048592 | ||
Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action | Q49048616 | ||
Extensive evacuation of subarachnoid clot for prevention of vasospasm--effective or not? | Q49048659 | ||
Cerebral vasodilation and prostacyclin. The effects of aspirin and meclofenamate in vitro | Q67236172 | ||
Blood clot evacuation in aneurysm surgery in the acute stage (arguments pro and con) | Q70419478 | ||
The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management | Q70419511 | ||
Some examples of balloon technology in neurosurgery | Q71144551 | ||
Lipid peroxidation as a cause of cerebral vasospasm | Q72459820 | ||
Pathogenesis of cerebral vasospasm | Q72459829 | ||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | surgery | Q40821 |
catheterization | Q2312472 | ||
P304 | page(s) | 65-79 | |
P577 | publication date | 1984-01-01 | |
P1433 | published in | Acta Neurochirurgica | Q15749688 |
P1476 | title | Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH | |
P478 | volume | 70 |
Q37799036 | A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology |
Q42062352 | Application of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography to neurologic prognosis in patients undergoing urgent carotid surgery |
Q48496138 | Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. |
Q39368282 | Balloon angioplasty immediately after surgical clipping for symptomatic vasospasm on admission. Report of four cases |
Q42118461 | Biochemomechanics of cerebral vasospasm and its resolution: I. A new hypothesis and theoretical framework. |
Q33491320 | Cerebral arterial aneurysms: the early period of neuroendovascular therapy |
Q35025753 | Cerebral artery restenosis following transluminal balloon angioplasty for vasospasm after subarachnoid hemorrhage |
Q90475173 | Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage |
Q43581417 | Clinical outcomes of aneurysmal subarachnoid hemorrhage patients treated with oral diltiazem and limited intensive care management |
Q48124048 | Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results |
Q37901420 | Critical care guidelines on the endovascular management of cerebral vasospasm |
Q40574451 | Critical care of patients with subarachnoid hemorrhage. |
Q38171354 | Current management of delayed cerebral ischemia: update from results of recent clinical trials |
Q33653064 | Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature |
Q38169976 | Delayed neurological deterioration after subarachnoid haemorrhage |
Q71760255 | Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage |
Q48307832 | Endovascular Rescue Therapies for Refractory Vasospasm After Subarachnoid Hemorrhage: A Prospective Evaluation Study Using Multimodal, Continuous Event Neuromonitoring |
Q47109016 | Endovascular Treatment of Symptomatic Vasospasm after Aneurysmal Subarachnoid Hemorrhage: A Three-year Experience. |
Q33777487 | Endovascular therapy for aneurysmal vasospasm |
Q33931351 | Endovascular treatment of cerebral vasospasm |
Q72305279 | Endovascular treatment of intracranial aneurysms |
Q33793254 | Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage |
Q48467388 | Endovascular treatment of vasospasm related to acute subarachnoid hemorrhage from ruptured aneurysms |
Q40703353 | Endovascular treatment of vasospasm. |
Q67899472 | Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage |
Q72024255 | Hemorheological and Hemodynamic Analysis of Hypervolemic Hemodilution Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage |
Q36334176 | Iatrogenic Intracerebral Hemorrhage |
Q44427217 | Impact of percutaneous transluminal angioplasty for treatment of cerebral vasospasm on subarachnoid hemorrhage patient outcomes |
Q41463173 | In Premature Newborns Intraventricular Hemorrhage Causes Cerebral Vasospasm and Associated Neurodisability via Heme-Induced Inflammasome-Mediated Interleukin-1 Production and Nitric Oxide Depletion |
Q78578874 | Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati |
Q97564542 | Interventional Neuroradiology: A Review |
Q81351729 | Interventional endovascular therapy: SPECT cerebral blood flow imaging compared with transcranial doppler monitoring of balloon angioplasty and intraarterial papaverine for cerebral vasospasm |
Q30498577 | Interventional neuroradiology |
Q39457775 | Interventional neuroradiology: an emerging subspeciality |
Q41354211 | Intra-aneurysmal GDC embolization followed by intrathecal tPA administration for poor-grade basilar tip aneurysm |
Q71370611 | Intra-arterial infusion of papaverine combined with intravenous administration of high-dose nicardipine for cerebral vasospasm |
Q34450489 | Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage |
Q34399469 | Intra-arterial papaverine-induced seizures: case report and review of the literature |
Q30472214 | Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm |
Q46435698 | Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results |
Q71522605 | Management of aneurysmal subarachnoid hemorrhage |
Q36406563 | Management of cerebral vasospasm |
Q36979411 | Management of subarachnoid haemorrhage |
Q38077694 | Management of vasospasm in ruptured unsecured intracranial vascular lesions: review of 10 cases |
Q40703365 | Materials and embolic agents for endovascular treatment. |
Q37574235 | Mechanical treatment of vasospasm |
Q31105955 | Mechanism of action of balloon angioplasty in cerebral vasospasm |
Q40477995 | Mechanisms of cerebral vasospasm in subarachnoid haemorrhage |
Q52509018 | Morphological Changes in Human Cerebral Arteries after Percutaneous Transluminal Angioplasty for Vasospasm Caused by Subarachnoid Hemorrhage |
Q48239369 | Morphological changes after percutaneous transluminal angioplasty |
Q44379553 | Neurointerventional treatment of amphetamine-induced acute occlusion of the middle cerebral artery by intracranial balloon angioplasty |
Q36681490 | Neurointerventional treatment of vasospasm |
Q81665181 | Outcome of aneurysmal subarachnoid haemorrhage following the introduction of papaverine angioplasty |
Q45049288 | Outcomes after nontraumatic subarachnoid hemorrhage at hospitals offering angioplasty for cerebral vasospasm: a national level analysis in the United States |
Q52509275 | Pharmacological and morphological effects of in vitro transluminal balloon angioplasty on normal and vasospastic canine basilar arteries |
Q68429570 | Pre-operative micro-angioplasty of refractory vasospasm secondary to subarachnoid hemorrhage |
Q40927740 | Protection of the brain after aneurysmal rupture. |
Q37691273 | Quadruple H therapy for vasospasm |
Q33491322 | Radiographic assessment of vasospasm after aneurysmal subarachnoid hemorrhage: the physiological perspective |
Q38287055 | Rescue therapy for refractory vasospasm after subarachnoid hemorrhage |
Q37718233 | Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage |
Q71855694 | Safety and Efficacy of Percutaneous Transluminal Angioplasty for Intracranial Atherosclerotic Stenosis |
Q52947551 | Safety and efficacy of balloon angioplasty of the anterior cerebral artery for vasospasm treatment after subarachnoid hemorrhage. |
Q34902428 | Safety and efficacy of transluminal balloon angioplasty using a compliant balloon for severe cerebral vasospasm after an aneurysmal subarachnoid hemorrhage |
Q34975153 | Simultaneous endovascular treatment of ruptured cerebral aneurysms and vasospasm |
Q34067390 | Subarachnoid haemorrhage: epidemiology, risk factors, and treatment options |
Q30472338 | Surgical treatment of the ruptured aneurysm. Timing. |
Q53660659 | The history of endovascular therapy. |
Q33427283 | The role of hyperbaric oxygen in the management of subarachnoid hemorrhage |
Q34977035 | Therapeutic approaches to cerebral vasospasm complicating ruptured aneurysm |
Q68445130 | Transluminal angioplasty for treatment of vasospasm |
Q36230958 | Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis |
Q46370322 | Treatment of cerebral vasospasm with self-expandable retrievable stents: proof of concept. |
Q33658415 | Treatment of intracranial vasospasm following subarachnoid hemorrhage |
Q37115479 | Update on subarachnoid haemorrhage |
Q81678827 | Vasospasm |
Q42007850 | Vasospasm and delayed consequences |
Q41363169 | Vasospasm and the timing of aneurysm surgery; have we progressed? |
Q82835426 | [Endovascular treatment of cerebral vasospasm due to aneurysmal subarachnoid hemorrhage] |
Q71399735 | [Endovascular treatment of vasospasm] |
Q80059362 | [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm] |
Search more.